Articles with the keyword: 
New antibiotic beats superbugs at their own game
kavin submitted, created time 2 years 2 months (esciencenews.com)
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for the great majority of staphylococcal infections worldwide, both in hospitals and in the community 
Fluoroquinolone-associated tendinopathy: a case report
Reviver submitted, created time 3 years 1 month (www.jmedicalcasereports.com)
"Fluoroquinolone-associated tendinopathy is well described. This adverse effect however does not appear to be widely known among medical practitioners. Researchers hereby described a case of ciprofloxacin-associated tendinopathy for which the adverse drug reaction was not suspected initially and the patient was inappropriately reassured and incorrectly advised to complete the antibiotic course
Older Antifungal Still a Good Choice Against Tough Infections
annatto submitted, created time 3 years 2 months (www.forbes.com)
A new study shows an older, cheaper medication to treat potentially deadly fungal infections may work just as well as a newer drug in most cases.
Drug-proof staph infections rising in Chicago
julie submitted, created time 3 years 3 months (www.msnbc.msn.com)
"Drug-resistant staph infections have spread to the urban poor, rising almost sevenfold in recent years in some Chicago neighborhoods, a new study finds.
"
\ 1
\ 
abuse@discover8.com
Darkfrog
angelfish
jane2007
Sue Wu
DanyC
Standard custom peptide synthesis: starting at $3.2 per amino acid; instant online quotations and ordering; high success rate via microwave synthesis technology.
www.genscript.com
Biology CRO for Drug Discovery
GenScript is a leading biology CRO focusing exclusively on early drug discovery and development services.
www.genscript.com